Alerte De Sécurité sur FreeStyle Libre Flash Glucose Monitoring System

Selon Department of Health, ce/cet/cette alerte de sécurité concerne un dispositif en/au/aux/à Hong Kong qui a été fabriqué par Abbott Diabetes Care.

Qu'est-ce que c'est?

Les alertes fournissent des informations importantes et des recommandations concernant les dispositifs médicaux. Le fait qu'une alerte soit émise ne signifie pas nécessairement qu'un dispositif soit dangereux. Les alertes de sécurité, qui sont envoyées tant aux travailleurs du secteur médical qu'aux utilisateurs de ces dispositifs, peuvent inclure des rappels. Elles peuvent être rédigées par des fabricants mais aussi par des autorités en charge de la santé.

En savoir plus sur les données ici
  • Type d'événement
    Safety alert
  • Date
  • Date de publication de l'événement
  • Pays de l'événement
  • Source de l'événement
  • URL de la source de l'événement
  • Notes / Alertes
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • Notes supplémentaires dans les données
    Medical Device Safety Alert
  • Cause
    Medical device safety alert: abbott diabetes care freestyle libre flash glucose monitoring system the medicines and healthcare products regulatory agency (mhra), united kingdom posted a field safety notice (fsn) concerning freestyle libre flash glucose monitoring system, manufactured by abbott diabetes care. according to the fsn, one of the safety features of the freestyle libre system is the software, which is designed to disable the sensor if it identifies a possible loss of sensor power. in rare cases this disabling feature may not function correctly, and there is the potential for power loss to occur which may not be properly identified by the system. in these instances, when a scan is completed the sensor may provide previously collected glucose values as if they are current results. if this occurs, the results produced from the scan and seen on the reader screen may be erroneous. however, the built-in blood glucose meter system is unaffected by this issue. the above issue can be easily identified as the user would see the same glucose result on the screen each time they scanned during a period of power loss. they may also notice a gap in results on the 8-hour graph on the reader screen. if any reading from a scan seems unexpected or does not seem to match the way users are feeling, users should use the meter and test strips to perform a blood glucose test to verify the results produced by a scan. if the problem continues, users should contact abbott diabetes care customer service. furthermore, the manufacturer has made a change to the software that has corrected this issue for all newly manufactured freestyle libre sensors. for details, please refer to mhra website : http://www.Mhra.Gov.Uk/safetyinformation/safetywarningsalertsandrecalls/fieldsafetynotices/con462307 according to the local supplier, the affected products were not distributed in hong kong. if you are in possession of the affected product, please contact your supplier for necessary actions. posted on 14 october 2014.


  • Modèle / numéro de série
  • Description du dispositif
    Medical Device Safety Alert: Abbott Diabetes Care FreeStyle Libre Flash Glucose Monitoring System
  • Manufacturer


  • Société-mère du fabricant (2017)
  • Commentaire du fabricant
    “We are in constant communication with regulatory agencies and competent authorities worldwide which allows us to implement global recalls or in-country communication quickly and effectively,” Abbott, which now owns St. Jude Medical told ICIJ in a statement. In addition to sending global notices to physicians worldwide, we also make sure that product advisories are available online and classification of product recalls and product advisories are determined by global regulatory bodies which can impact the timing in any given country. MD companies follow varying regulations in different countries. In come countries software is not regulated so a recall in one country related to software would not be classified as a recall or field action in another. In addition, review cycles within the regulatory process can be different in each country which can impact communication and recall timing.
  • Source